Scarica l'app Stockscreener
143.50
1.24%
-1.80
Dopo l'orario di chiusura:
144.60
1.10
+0.77%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$145.30
Aprire:
$145
Volume 24 ore:
2.50M
Relative Volume:
0.66
Capitalizzazione di mercato:
$30.33B
Reddito:
$398.11M
Utile/perdita netta:
$-1.03B
Rapporto P/E:
-25.22
EPS:
-5.69
Flusso di cassa netto:
$-868.57M
1 W Prestazione:
+6.67%
1M Prestazione:
+32.03%
6M Prestazione:
+88.10%
1 anno Prestazione:
+95.76%
Intervallo 1D:
$142.36
$146.84
Intervallo di 1 settimana:
$134.19
$146.84
Portata 52W:
$60.40
$146.84
Insmed Inc Stock (INSM) Company Profile
Nome
Insmed Inc
Settore
Industria
Telefono
908-977-9900
Indirizzo
700 US HIGHWAY 202/206, BRIDGEWATER, NJ
Confronta INSM con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
INSM
Insmed Inc
|
143.50 | 30.71B | 398.11M | -1.03B | -868.57M | -5.69 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.62 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.80 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
447.43 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
722.01 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
336.26 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Insmed Inc Stock (INSM) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-20 | Iniziato | William Blair | Outperform |
| 2025-08-13 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2025-05-13 | Iniziato | Jefferies | Buy |
| 2025-02-25 | Iniziato | RBC Capital Mkts | Outperform |
| 2024-04-23 | Iniziato | Truist | Buy |
| 2024-02-15 | Iniziato | Wolfe Research | Outperform |
| 2023-12-08 | Iniziato | Wells Fargo | Overweight |
| 2023-11-20 | Ripresa | JP Morgan | Overweight |
| 2023-07-26 | Iniziato | Guggenheim | Buy |
| 2022-12-09 | Iniziato | Mizuho | Buy |
| 2022-12-07 | Iniziato | Barclays | Overweight |
| 2022-11-18 | Iniziato | BofA Securities | Buy |
| 2022-04-27 | Iniziato | Goldman | Buy |
| 2021-12-06 | Iniziato | JP Morgan | Overweight |
| 2021-10-19 | Ripresa | Monness Crespi & Hardt | Buy |
| 2021-10-19 | Ripresa | Morgan Stanley | Overweight |
| 2021-10-08 | Iniziato | Cantor Fitzgerald | Overweight |
| 2021-04-26 | Ripresa | Credit Suisse | Outperform |
| 2020-12-17 | Iniziato | Berenberg | Buy |
| 2020-10-12 | Ripresa | Stifel | Buy |
| 2019-09-03 | Iniziato | Goldman | Buy |
| 2019-04-09 | Reiterato | H.C. Wainwright | Buy |
| 2019-02-15 | Aggiornamento | JMP Securities | Mkt Perform → Mkt Outperform |
| 2019-01-17 | Aggiornamento | Goldman | Neutral → Buy |
| 2019-01-02 | Iniziato | Canaccord Genuity | Buy |
| 2018-08-06 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| 2018-07-23 | Iniziato | Goldman | Neutral |
| 2018-04-23 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2018-03-21 | Iniziato | Morgan Stanley | Overweight |
| 2018-01-18 | Iniziato | Credit Suisse | Neutral |
| 2017-09-05 | Reiterato | Evercore ISI | Outperform |
| 2017-08-17 | Iniziato | Evercore ISI | Outperform |
| 2017-07-11 | Iniziato | Robert W. Baird | Outperform |
| 2016-03-15 | Iniziato | Stifel | Buy |
| 2015-11-09 | Downgrade | UBS | Buy → Neutral |
| 2015-10-06 | Reiterato | H.C. Wainwright | Buy |
| 2015-06-09 | Iniziato | Citigroup | Neutral |
| 2014-03-26 | Reiterato | HC Wainwright | Buy |
Mostra tutto
Insmed Inc Borsa (INSM) Ultime notizie
Will Insmed Incorporated benefit from rate cutsRecession Risk & Smart Money Movement Alerts - khodrobank.com
Should you wait for a breakout in Insmed IncorporatedMarket Movement Recap & High Accuracy Buy Signal Tips - Newser
Analyzing drawdowns of Insmed Incorporated with statistical tools2025 Market Sentiment & Free Real-Time Market Sentiment Alerts - Newser
Key resistance and support levels for Insmed IncorporatedQuarterly Growth Report & Capital Efficient Trading Techniques - Newser
Is Insmed Incorporated forming a reversal patternTrade Signal Summary & Growth Oriented Trading Recommendations - Newser
Live market analysis of Insmed IncorporatedShare Buyback & Step-by-Step Trade Execution Guides - Newser
Analyzing net buyer seller activity in Insmed IncorporatedWeekly Trend Summary & Real-Time Stock Movement Alerts - Newser
Sentiment analysis tools applied to Insmed IncorporatedWeekly Stock Analysis & Daily Entry Point Trade Alerts - Newser
Chart based exit strategy for Insmed IncorporatedEarnings Beat & Risk Controlled Stock Alerts - Newser
Is Insmed Incorporated still worth holding after the dip2025 Market Sentiment & Real-Time Stock Price Movement Reports - Newser
Insmed (INSM) Soars 6.76% After FDA Approves Brinsupri for Non-CF Bronchiectasis - AInvest
Will Insmed Incorporated outperform small cap indexesWeekly Trade Review & AI Forecast for Swing Trade Picks - khodrobank.com
Insmed (INSM) Surges 6.76% on Bullish Technical Signals Faces Key Resistance at $140 - AInvest
Is Insmed Incorporated stock forming a cup and handleMarket Sentiment Summary & Entry Point Confirmation Alerts - khodrobank.com
Why United Just Catapulted 39%, Pulling Two Rivals With It - Investor's Business Daily
Brinsupri Boost: Is Insmed Stock Undervalued? - StocksToTrade
What high frequency data says about Insmed Incorporated2025 AllTime Highs & Free Daily Entry Point Trade Alerts - Newser
Insmed Stock Soars: Buy or Hold Timeout? - timothysykes.com
Insmed Stock Jumps: What’s Driving Change? - StocksToTrade
What analysts say about Insmed Incorporated stockEarnings Risk Report & Growth Focused Stock Pick Reports - khodrobank.com
Buy Rating for Insmed: Promising Market Potential and Strategic Advancements in TPIP Development - TipRanks
Will earnings trigger a reversal in Insmed IncorporatedWeekly Risk Summary & Fast Exit/Entry Strategy Plans - Newser
Insmed Surges 5.9% on Intraday Rally: What’s Fueling the Momentum? - AInvest
Custom watchlist performance reports with Insmed Incorporated2025 Sector Review & Safe Investment Capital Preservation Plans - Newser
S&P 500 Futures Decline in Premarket Trading; Insmed, Millrose Properties Lead - Barron's
Combining price and volume data for Insmed IncorporatedWeekly Loss Report & High Conviction Trade Alerts - Newser
Is Insmed Incorporated forming a double bottomJuly 2025 Technicals & Long-Term Growth Stock Strategies - khodrobank.com
Signal strength of Insmed Incorporated stock in tech scanners2025 Momentum Check & Weekly Breakout Watchlists - Newser
What Fibonacci levels say about Insmed Incorporated reboundJuly 2025 Setups & Technical Pattern Based Buy Signals - Newser
Is it time to cut losses on Insmed IncorporatedWeekly Investment Summary & Accurate Buy Signal Alerts - Newser
Published on: 2025-09-01 13:30:18 - beatles.ru
Is this a good reentry point in Insmed IncorporatedTrade Ideas & Expert Curated Trade Ideas - Newser
Analyzing Insmed Incorporated with risk reward ratio chartsJuly 2025 Sector Moves & High Win Rate Trade Tips - Newser
Intraday pattern recognizer results for Insmed IncorporatedQuarterly Portfolio Review & Risk Controlled Daily Plans - Newser
Predicting Insmed Incorporated trend using moving averagesBreakout Watch & Verified Technical Trade Signals - Newser
Will Insmed Incorporated Benefit From Sector Tailwinds getLinesFromResByArray error: size == 0 - thegnnews.com
Is Insmed Incorporated stock entering bullish territoryEarnings Summary Report & AI Forecast Swing Trade Picks - Newser
Exit strategy if you’re trapped in Insmed IncorporatedTrade Volume Summary & Short-Term High Return Ideas - Newser
Will Insmed Incorporated outperform the marketMarket Trend Review & Precise Buy Zone Tips - Newser
How sentiment analysis helps forecast Insmed IncorporatedQuarterly Earnings Report & Consistent Profit Trading Strategies - Newser
Relative strength of Insmed Incorporated in sector analysis2025 Market Sentiment & Community Driven Trade Alerts - Newser
Insmed Inc Azioni (INSM) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.20%
1.27%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):